Sign Up
av/ocuphire-pharma--big.svg

COM:OCUPHIRE

Opus Genetics

  • Stock

USD

Last Close

1.33

23/10 20:00

Market Cap

42.77M

Beta: -

Volume Today

675.97K

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.02
-
0.81
3,501.19%
0.35
56.59%
cash conversion cycle
-130.93K
-
cash per share
0.15
-
0.19
27.14%
0.13
30.78%
0.09
27.30%
0.98
948.49%
0.45
54.33%
0.64
42.91%
3.52
450.28%
1.67
52.63%
2.14
28.50%
2.34
9.26%
company equity multiplier
1.55
-
1.26
18.55%
1.32
4.72%
1.23
6.62%
1.69
36.75%
1.52
9.97%
-0.24
115.54%
-1.31
456.40%
1.17
189.37%
1.06
9.71%
1.08
2.02%
days of inventory outstanding
days of payables outstanding
130.97K
-
days of sales outstanding
44.42
-
44.70
0.63%
dividend yield
ebit per revenue
-38.55
-
0.46
101.19%
-0.55
221.24%
ebt per ebit
1.19
-
1.40
17.24%
0.79
43.57%
0.57
28.00%
1.46
157.03%
0.70
52.00%
1.47
110.29%
1.23
16.20%
2.50
102.51%
1.00
60.00%
0.94
5.46%
effective tax rate
-0.22
-
-0.28
28.11%
0.00
101.01%
0.02
517.02%
-0.00
106.95%
enterprise value multiple
-3.96K
-
-4.46K
12.50%
-1.73K
61.31%
-889.57
48.43%
-152.52
82.86%
-71.12
53.37%
-13.69
80.74%
-1.47
89.30%
-1.37
6.29%
1.52
210.81%
-1.37
190.13%
fixed asset turnover
58.90
-
6.64K
11,176.17%
free cash flow per share
-0.06
-
-0.06
1.01%
-0.10
51.74%
-0.06
36.06%
-0.56
825.50%
-0.57
1.66%
-0.51
10.86%
-1.46
185.84%
-1.30
10.57%
0.72
155.07%
-0.05
107.17%
gross profit margin
1
-
1
0%
1.00
0.03%
interest coverage
-2.98
-
-2.92
2.00%
-11.35K
389,175.68%
2.03K
117.84%
inventory turnover
long term debt to capitalization
-0.01
-
net income per ebt
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1.22
21.74%
1.28
5.02%
1.00
22.00%
0.98
1.45%
1.00
1.88%
net profit margin
-95.98
-
0.45
100.47%
-0.52
216.78%
operating cash flow per share
-0.06
-
-0.06
1.01%
-0.10
51.74%
-0.06
36.06%
-0.56
825.50%
-0.57
1.66%
-0.51
11.48%
-1.46
187.83%
-1.30
10.57%
0.72
155.07%
-0.05
107.17%
operating cycle
44.70
-
operating profit margin
-38.55
-
0.46
101.19%
-0.55
221.24%
payables turnover
0.00
-
pretax profit margin
-96.25
-
0.46
100.47%
-0.52
214.63%
price fair value
2.49K
-
2.23K
10.76%
1.68K
24.60%
856.61
48.97%
158.38
81.51%
139.10
12.17%
-7.17
105.15%
-2.25
68.66%
2.49
210.99%
1.52
38.97%
1.30
14.42%
receivables turnover
8.22
-
8.17
0.63%
return on assets
-0.49
-
-0.55
13.71%
-0.58
4.99%
-0.44
23.73%
-0.89
102.17%
-0.90
0.16%
-4.21
370.02%
-1.78
57.71%
-2.17
21.79%
0.37
116.84%
-0.19
150.70%
return on capital employed
-0.41
-
-0.40
3.01%
-0.74
86.07%
-0.78
5.93%
-0.61
21.34%
-1.28
108.67%
0.55
143.32%
-1.38
348.34%
-1.02
25.82%
0.39
138.58%
-0.21
153.70%
return on equity
-0.75
-
-0.70
7.39%
-0.77
9.95%
-0.55
28.78%
-1.51
176.47%
-1.36
9.82%
0.99
173.03%
2.34
135.28%
-2.54
208.85%
0.39
115.21%
-0.20
151.72%
total debt to capitalization
-3.13
-
0.02
-

All numbers in USD (except ratios and percentages)